PFIZER - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.7
| Stock Code | PFIZER | Market Cap | 22,045 Cr. | Current Price | 4,823 ₹ | High / Low | 5,993 ₹ |
| Stock P/E | 29.0 | Book Value | 841 ₹ | Dividend Yield | 0.73 % | ROCE | 21.6 % |
| ROE | 16.4 % | Face Value | 10.0 ₹ | DMA 50 | 4,869 ₹ | DMA 200 | 4,976 ₹ |
| Chg in FII Hold | 0.11 % | Chg in DII Hold | -0.06 % | PAT Qtr | 182 Cr. | PAT Prev Qtr | 189 Cr. |
| RSI | 48.8 | MACD | -46.1 | Volume | 13,644 | Avg Vol 1Wk | 41,280 |
| Low price | 3,701 ₹ | High price | 5,993 ₹ | PEG Ratio | 18.3 | Debt to equity | 0.01 |
| 52w Index | 49.0 % | Qtr Profit Var | 43.0 % | EPS | 187 ₹ | Industry PE | 27.6 |
📊 Analysis: PFIZER trades at ₹4,823, slightly below both 50 DMA (₹4,869) and 200 DMA (₹4,976), showing short-term weakness. RSI at 48.8 and MACD negative (-46.1) confirm subdued momentum. Volume is far below weekly average, reducing intraday conviction. Fundamentals remain strong with ROCE 21.6%, ROE 16.4%, and EPS ₹187, but valuation is stretched with PEG ratio 18.3. Intraday bias is mildly bearish with limited upside.
💡 Optimal Buy Price: ₹4,800–4,820 if price stabilizes near support.
🎯 Profit Exit Levels: ₹4,880 (first target), ₹4,940 (second target).
🛡️ Stop-Loss: ₹4,770 (below intraday support).
⏱️ If Already Holding: Exit near ₹4,880–4,940 if momentum weakens. If price breaks below ₹4,770 with volume spike, cut position immediately.
✅ Positive
- Strong ROCE (21.6%) and ROE (16.4%).
- EPS at ₹187 shows robust earnings base.
- Debt-to-equity ratio at 0.01, virtually debt-free.
- FII holdings increased slightly (+0.11%).
⚠️ Limitation
- Stock trades below both 50 DMA and 200 DMA.
- MACD negative (-46.1), momentum weak.
- Volume significantly below weekly average, reducing intraday conviction.
- High PEG ratio (18.3) indicates expensive valuation relative to growth.
📉 Company Negative News
- DII holdings decreased (-0.06%).
- Quarterly PAT declined from ₹189 Cr. to ₹182 Cr.
📈 Company Positive News
- Quarterly profit variation shows +43% YoY improvement despite sequential dip.
- Dividend yield at 0.73% adds investor appeal.
🏭 Industry
- Industry P/E at 27.6, PFIZER trades at 29.0, slightly above sector average.
- Pharma sector demand remains resilient, supported by healthcare spending.
🔎 Conclusion
PFIZER is a moderate-risk intraday candidate. Momentum indicators suggest caution, but strong fundamentals and debt-free balance sheet support stability. Best approach: buy near ₹4,800–4,820, exit at ₹4,880–4,940, and protect downside with stop-loss at ₹4,770.
Would you like me to extend this into a basket overlay with peer benchmarking (e.g., Sun Pharma, Dr. Reddy’s, Cipla) so you can compare PFIZER’s intraday strength against other pharma sector leaders? This will highlight whether PFIZER is lagging or leading relative to its peers.